Health care stocks fell Monday afternoon with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) both shedding 0.6%.
The iShares Biotechnology ETF (IBB) rose 0.4%.
In corporate news, BioNTech (BNTX) expects full-year revenue at the low end of guidance due in part to inventory writedowns, even as variant-adapted COVID-19 vaccines helped boost Q3 results. The shares fell 0.7%.
PACS (PACS) shares tumbled 28% following a report by short-seller Hindenburg Research.
AstraZeneca (AZN) said its experimental obesity pill was well-tolerated by people with type-2 diabetes, Bloomberg reported, citing comments made by a company executive at an industry conference. AstraZeneca shares eased 0.2%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.